Day One Biopharmaceuticals, Inc.
DAWN
$6.32
-$0.09-1.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.94% | 49.45% | 51.70% | -0.79% | -33.23% |
| Total Depreciation and Amortization | 584.63% | 429.77% | 198.48% | 38.02% | -27.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -139.89% | -134.49% | -135.00% | -347.00% | 24.80% |
| Change in Net Operating Assets | -329.00% | 181.16% | -19.45% | 347.24% | -77.58% |
| Cash from Operations | 48.78% | 46.81% | 36.45% | -39.67% | -49.26% |
| Capital Expenditure | -1,155.56% | -868.30% | -250.93% | 58.10% | -435.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -252.98% | -277.93% | -27.31% | 194.13% | 186.04% |
| Cash from Investing | -254.20% | -279.93% | -27.94% | 194.02% | 185.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.94% | 11.19% | 9.54% | -98.77% | -2.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24.80% | 23.96% | 22.21% | -98.77% | -2.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.20% | -172.71% | 50.93% | 125.24% | 203.59% |